Daniel D. Shoemaker, Chief Scientific Officer at FATE THERAPEUTICS INC (FATE), sold 46,300 shares at $78.60 ($3.8M) on 2021-03-08, disclosed to the SEC on 2021-03-09.
Open-market sale of $3.8M FATE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.60 | 3,298 | $259K | 6.9% |
| 2 | $78.60 | 3,298 | $259K | 6.9% |
| 3 | $79.58 | 4,627 | $368K | 9.8% |
| 4 | $79.58 | 4,627 | $368K | 9.8% |
| 5 | $80.73 | 5,174 | $418K | 11.1% |
| 6 | $80.73 | 5,174 |
| $418K |
| 11.1% |
| 7 | $81.60 | 2,993 | $244K | 6.5% |
| 8 | $81.60 | 2,993 | $244K | 6.5% |
| 9 | $83.46 | 2,480 | $207K | 5.5% |
| 10 | $83.46 | 2,480 | $207K | 5.5% |
| 11 | $84.20 | 2,728 | $230K | 6.1% |
| 12 | $84.20 | 2,728 | $230K | 6.1% |
| 13 | $85.50 | 2,900 | $248K | 6.6% |
| 14 | $86.70 | 800 | $69K | 1.8% |
| Total | $81.41 avg | 46,300 | $3.8M | 100% |
| Filing → |
| FATE | SELL | 2020-09-16 | $1.8M | — | Filing → |
| FATE | SELL | 2020-01-10 | $118K | — | Filing → |
| FATE | SELL | 2020-01-02 | $973K | — | Filing → |